drugset / Trial / NCT02390375
Phase 3 Study to Evaluate the Efficacy and Safety of the DW0929 in Patients With Primary Hypercholesterolemia
RandomizedFactorialDouble-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of the DW0929 in patients with primary hypercholesterolemia
Timeline
- Start
- 2014-11
- Primary completion
- 2016-04
- Completion
- 2016-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DW-0929 | Unknown | 5 mg | — |
| Subject | DW-0929 | Unknown | 10 mg | — |
| Subject | DW-0929 | Unknown | 20 mg | — |
| Comparator | Rosuvastatin | Small molecule | 5 mg | — |
| Comparator | Rosuvastatin | Small molecule | 10 mg | — |
| Comparator | Rosuvastatin | Small molecule | 20 mg | — |